RQM-62744-04518
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 262 / WV
- Registered
- 2022-01-15
- Relationship
- Child or adolescent in my care
- Guardian
- 5C8-53536-86258
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-09-22
Dose 1 — Pfizer-BioNTech
-
2021-10-20
Dose 2 — Pfizer-BioNTech
-
2022-01-15
Registered in v-safe
-
2022-01-19
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Diarrhoea, Oropharyngeal pain, Sneezing — Feeling: FairFree text: Diarrhea, sore throat, sneezing, dry coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-22 | Pfizer-BioNTech | No |
| 2 | 2021-10-20 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2, dependent
Symptoms: Diarrhea, sore throat, sneezing, dry cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release